Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
35M
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
10.8M
-
Shares change
-
+10.2M
-
Total reported value, excl. options
-
$215M
-
Value change
-
+$202M
-
Number of buys
-
27
-
Price
-
$19.89
Significant Holders of Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) as of Q4 2022
31 filings reported holding IRON - Disc Medicine, Inc. - Common Stock, $0.0001 par value per share as of Q4 2022.
Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.8M shares
of 35M outstanding shares and own 30.87% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (3.46M shares), Novo Holdings A/S (2.34M shares), ORBIMED ADVISORS LLC (2.16M shares), 5AM Venture Management, LLC (588K shares), BML Capital Management, LLC (500K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (350K shares), Rock Springs Capital Management LP (339K shares), Foresite Capital Management V, LLC (244K shares), FMR LLC (193K shares), and Nantahala Capital Management, LLC (163K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.